Breaking News Instant updates and real-time market news.

FTDR

Frontdoor

$31.90

-0.88 (-2.68%)

, LPSN

LivePerson

$28.54

0.29 (1.03%)

10:20
03/25/19
03/25
10:20
03/25/19
10:20

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Frontdoor (FTDR) initiated with an Overweight at JPMorgan. 2. LivePerson (LPSN) initiated with an Overweight at Piper Jaffray. 3. Kaleido Biosciences (KLDO) initiated with an Overweight at Morgan Stanley, a Buy at Canaccord and Goldman Sachs, and a Neutral at JPMorgan. 4. Fox Corp. (FOXA) initiated with a Hold at Loop Capital and an Overweight at JPMorgan. 5. Gold Resource (GORO) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

FTDR

Frontdoor

$31.90

-0.88 (-2.68%)

LPSN

LivePerson

$28.54

0.29 (1.03%)

KLDO

Kaleido Biosciences

$13.94

0.04 (0.29%)

FOXA

Fox Corp.

$37.95

-0.68 (-1.76%)

GORO

Gold Resource

$4.08

0.21 (5.43%)

  • 28

    May

  • 20

    Jun

FTDR Frontdoor
$31.90

-0.88 (-2.68%)

03/25/19
JPMS
03/25/19
INITIATION
Target $41
JPMS
Overweight
Frontdoor initiated with an Overweight at JPMorgan
JPMorgan analyst Cory Carpenter started Frontdoor with an Overweight rating and $41 price target. The analyst views the company's scale is a key competitive advantage and believes its home service plan business is well positioned with "multiple" growth drivers.
11/30/18
BUCK
11/30/18
INITIATION
Target $29
BUCK
Buy
Frontdoor initiated with a Buy at Buckingham
Buckingham analyst James Clement initiated Frontdoor (FTDR) with a Buy rating and $29 price target. He believes the stock's "very poor" trading since its spinoff from ServiceMaster (SERV) on October 1 provides a buying opportunity, stating that Frontdoor is in the process of raising prices and he thinks it has plenty of room to do so. Clement believes the most attractive long-term aspect of the story is the potential for Frontdoor to be a disruptor in home improvement, maintenance and repairs, but acknowledges the company will have to invest significantly to make this a reality.
02/28/19
SPIN
02/28/19
UPGRADE
SPIN
Buy
Frontdoor upgraded to Buy from Hold at Spin-Off Research
03/25/19
WELS
03/25/19
INITIATION
Target $40
WELS
Outperform
Frontdoor initiated with an Outperform at Wells Fargo
Wells Fargo analyst Robert Coolbrith started coverage of Frontdoor with an Outperform rating and a $40 price target. Having commenced trading as a public company in October 2018 and under new management since mid-2018, the analyst notes that the company is in the midst of a number of operational improvement initiatives which he believes should drive continued solid revenue growth in the high single digit range and EBITDA margin expansion into the low-20s percentage range. A planned on-demand home services offering, which is expected to connect consumers with home services professionals for a broader array of services/projects and which will be piloted in the second half of 2019, offers an additional avenue for growth over the longer term, he adds.
LPSN LivePerson
$28.54

0.29 (1.03%)

01/24/19
01/24/19
UPGRADE
Target $31

Outperform
LivePerson upgraded to Outperform at Oppenheimer on improving fundamentals
As previously reported, Oppenheimer analyst Koji Ikeda upgraded LivePerson to Outperform from Perform, with a $31 price target, as he sees good upside from current price levels based on improving business fundamentals and valuation. Specifically, the analyst sees an underappreciated mobile commerce opportunity that can drive upside to estimates, a good entry point following the pull-back, several catalysts including a potential growth acceleration story in 2019 to about 20%, strong installed-base monetization opportunity; and anticipates a good execution trend over the FTM.
03/07/19
EVER
03/07/19
INITIATION
Target $34
EVER
Outperform
LivePerson initiated with an Outperform at Evercore ISI
Evercore ISI analyst Peter Levine initiated LivePerson wiht an Outperform and $34 price target saying it offers brands the ability to connect with customers across all their preferred channels. He believes LivePerson is benefiting from the broader trends around digital transformation initiatives , combined with a strong demographic trend towards chat/messaging for customer service and sales.
03/08/19
LEHM
03/08/19
INITIATION
Target $35
LEHM
Overweight
LivePerson initiated with an Overweight at Barclays
Barclays analyst Raimo Lenschow started LivePerson with an Overweight rating and $35 price target. The company offers exposure to the business-to-consumer messaging market at an attractive valuation, Lenschow tells investors in a research note.
03/25/19
PIPR
03/25/19
INITIATION
Target $39
PIPR
Overweight
LivePerson initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Alex Zukin started LivePerson with an Overweight rating and $39 price target. The analyst views the company as a "relatively inexpensive" way to play the business-to-consumer digital transformation trend as brands "look to fundamentally evolve their relationships with customers in a digital-first world." The secular shift of voice to messaging to artificial intelligence is both "real and massive," and as an early mover with legacy roots and advantages, LivePerson is well positioned, Zukin tells investors in a research note.
KLDO Kaleido Biosciences
$13.94

0.04 (0.29%)

03/25/19
GSCO
03/25/19
INITIATION
Target $20
GSCO
Buy
Kaleido Biosciences initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Terence Flynn started Kaleido Biosciences with a Buy rating and $20 price target. The analyst sees several pipeline catalysts over the next 18 months and projects KB174 has blockbuster potential in hepatic encephalopathy.
03/25/19
JPMS
03/25/19
INITIATION
Target $15
JPMS
Neutral
Kaleido Biosciences initiated with a Neutral at JPMorgan
JPMorgan analyst Jessica Fye started Kaleido Biosciences with a Neutral rating and $15 price target. The analyst wants to see more clinical validation supporting efficacy and safety in patients to de-risk the company's microbiome metabolic therapies platform before recommending the shares.
03/25/19
ADAM
03/25/19
INITIATION
Target $19
ADAM
Buy
Kaleido Biosciences initiated with a Buy at Canaccord
Canaccord analyst John Newman initiated Kaleido Biosciences with a Buy rating and $19 price target. The analyst believes KB195 could achieve about $310M in peak U.S. sales in 2030E for urea cycle disorder-incuded hyperammonemia and estimates about $596M in U.S. peak sales for KB174 in HE-induced hyperammonemia. The analyst also believes the company's MMT platform could be "highly efficient" and low cost, and sees a good buying opportunity ahead of several data readouts int he next 12-18 months.
03/25/19
MSCO
03/25/19
INITIATION
Target $17
MSCO
Overweight
Kaleido Biosciences initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison initiated Kaleido Biosciences with an Overweight rating and $17 price target, stating that he believes the company's platform for developing glycan molecules to modify the function of the gut is promising, particularly for hyperammonemia conditions. Harrison thinks the risk/reward is "skewed to the positive" ahead of Phase I/II hyperammonemia data in late 2019 and mid-2020, he tells investors.
FOXA Fox Corp.
$37.95

-0.68 (-1.76%)

03/25/19
JPMS
03/25/19
INITIATION
Target $46
JPMS
Overweight
Fox Corp. initiated with an Overweight at JPMorgan
JPMorgan analyst Alexia Quadrani started Fox Corp. with an Overweight rating and $46 price target. Fox has an "impressive mix of businesses," including "strong" cable channels and a major broadcast network with a leading local TV footprint, Quadrani tells investors in a research note. She believes the shares will maintain a premium valuation over the average in her large-cap media universe, implying "notable upside" to shares from the current level.
03/22/19
03/22/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Energizer (ENR) initiated with a Neutral at JPMorgan. 2. Fox Corp. (FOXA) initiated with an Equal Weight at Barclays. 3. Western Gas Partners (WES) initiated with an Equal Weight at Barclays. 4. Linde plc (LIN) initiated with a Hold at Argus. 5. SurveyMonkey (SVMK) initiated with an Overweight, named a Best Idea at Stephens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/22/19
LEHM
03/22/19
INITIATION
Target $40
LEHM
Equal Weight
Fox Corp. initiated with an Equal Weight at Barclays
Barclays analyst Kannan Venkateshwar started Fox Corp. with an Equal Weight rating and $40 price target. The key to multiple expansion is likely to be execution on a broadcast turnaround, Venkateshwar tells investors in a research note. The analyst views the stock as fairly priced relative to peers.
03/25/19
LOOP
03/25/19
INITIATION
Target $42
LOOP
Hold
Fox Corp. initiated with a Hold at Loop Capital
Loop Capital analyst Alan Gould initiated Fox Corp with a Hold rating and a price target of $42. The analyst notes that although the company is "well positioned for the evolving media world as a news and sports programmer with two channels that all distributors effectively must carry, Fox Broadcast and Fox News," its valuation stands at a premium to most of the traditional media companies. The analyst also warns that Fox's cable affiliate revenue growth is set to moderate even though its "corporate overhead will be elevated for the next couple of years."
GORO Gold Resource
$4.08

0.21 (5.43%)

03/25/19
HCWC
03/25/19
INITIATION
Target $7.75
HCWC
Buy
Gold Resource initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Heiko Ihle started Gold Resource with a Buy rating and $7.75 price target. The company provides investors a balance of precious and base metal production in geographically favorable jurisdictions, with additional near-term gold production, says the analyst.

TODAY'S FREE FLY STORIES

MRPLY

Mr Price Group

$0.00

(0.00%)

20:14
12/15/19
12/15
20:14
12/15/19
20:14
Upgrade
Mr Price Group rating change at JPMorgan »

Mr Price Group upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$341.67

-4.795 (-1.38%)

18:48
12/15/19
12/15
18:48
12/15/19
18:48
Periodicals
Boeing considering halting or cutting 737 MAX production, WSJ reports »

Boeing (BA) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XEL

Xcel Energy

$62.27

0.91 (1.48%)

18:42
12/15/19
12/15
18:42
12/15/19
18:42
Initiation
Xcel Energy initiated at Goldman Sachs »

Xcel Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQUA

Evoqua Water

$19.53

-0.6 (-2.98%)

18:38
12/15/19
12/15
18:38
12/15/19
18:38
Recommendations
Evoqua Water analyst commentary at Stifel »

Evoqua Water price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLSFY

Bluescope Steel

$0.00

(0.00%)

18:33
12/15/19
12/15
18:33
12/15/19
18:33
Upgrade
Bluescope Steel rating change at JPMorgan »

Bluescope Steel upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLSFY

Bluescope Steel

$0.00

(0.00%)

16:54
12/15/19
12/15
16:54
12/15/19
16:54
Upgrade
Bluescope Steel rating change at Macquarie »

Bluescope Steel upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$72.82

0.23 (0.32%)

16:36
12/15/19
12/15
16:36
12/15/19
16:36
Recommendations
Stifel adds Sage to Select List, says SAGE-217 will generate billions »

Stifel analyst Paul…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DD

DuPont

$64.79

-1.39 (-2.10%)

16:10
12/15/19
12/15
16:10
12/15/19
16:10
Earnings
DuPont sees 2019 operating EBITDA at low end of guidance range »

DuPont reconfirms its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

IFF

$134.01

-0.55 (-0.41%)

16:07
12/15/19
12/15
16:07
12/15/19
16:07
Earnings
IFF affirms existing 2019 guidance for sales and earnings »

IFF is affirming its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

IFF

$134.01

-0.55 (-0.41%)

16:05
12/15/19
12/15
16:05
12/15/19
16:05
Hot Stocks
IFF, DuPont unit see revenue growth in mid-single digits over long term »

The company created by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAS

Hasbro

$103.99

1.085 (1.05%)

, MAT

Mattel

$13.35

0.58 (4.54%)

16:03
12/15/19
12/15
16:03
12/15/19
16:03
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

HAS

Hasbro

$103.99

1.085 (1.05%)

MAT

Mattel

$13.35

0.58 (4.54%)

FNKO

Funko

$15.16

0.23 (1.54%)

JAKK

JAKKS Pacific

$0.94

-0.0244 (-2.54%)

BBW

Build-A-Bear

$2.70

-0.05 (-1.82%)

MAS

Masco

$47.00

-0.44 (-0.93%)

FBHS

Fortune Brands

$65.09

-0.42 (-0.64%)

SPY

SPDR S&P 500 ETF Trust

$317.27

0.13 (0.04%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

IFF

$134.01

-0.55 (-0.41%)

16:03
12/15/19
12/15
16:03
12/15/19
16:03
Hot Stocks
IFF to merge with DuPont's Nutrition & Biosciences unit via Reverse Morris Trust »

IFF (IFF) and DuPont (DD)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$134.01

-0.55 (-0.41%)

, DD

DuPont

$64.79

-1.39 (-2.10%)

15:58
12/15/19
12/15
15:58
12/15/19
15:58
Hot Stocks
Breaking Hot Stocks news story on International Flavors, DuPont »

DuPont to receive…

IFF

International Flavors

$134.01

-0.55 (-0.41%)

DD

DuPont

$64.79

-1.39 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$134.01

-0.55 (-0.41%)

, DD

DuPont

$64.79

-1.39 (-2.10%)

15:58
12/15/19
12/15
15:58
12/15/19
15:58
Hot Stocks
Breaking Hot Stocks news story on International Flavors, DuPont »

DuPont holders will own…

IFF

International Flavors

$134.01

-0.55 (-0.41%)

DD

DuPont

$64.79

-1.39 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$134.01

-0.55 (-0.41%)

, DD

DuPont

$64.79

-1.39 (-2.10%)

15:57
12/15/19
12/15
15:57
12/15/19
15:57
Recommendations
International Flavors, DuPont analyst commentary  »

International Flavors to…

IFF

International Flavors

$134.01

-0.55 (-0.41%)

DD

DuPont

$64.79

-1.39 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILL

Bill.com

$38.59

3.09 (8.70%)

, EH

Ehang

$12.87

0.39 (3.13%)

15:25
12/15/19
12/15
15:25
12/15/19
15:25
On The Fly
Opening Day: XP finishes first week higher, Sprout Social lower »

This past week saw six…

BILL

Bill.com

$38.59

3.09 (8.70%)

EH

Ehang

$12.87

0.39 (3.13%)

HCCO

Healthcare Merger Corp.

$0.00

(0.00%)

OCFT

OneConnect

$10.08

(0.00%)

SPT

Sprout Social

$16.76

(0.00%)

XP

XP

$37.61

3.235 (9.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$67.60

0.285 (0.42%)

, SCOR

comScore

$4.63

-0.41 (-8.13%)

15:09
12/15/19
12/15
15:09
12/15/19
15:09
Hot Stocks
Sony's 'Jumanji' tops weekend box office with $60.1M in sales »

Sony's (SNE)…

SNE

Sony

$67.60

0.285 (0.42%)

SCOR

comScore

$4.63

-0.41 (-8.13%)

DIS

Disney

$146.37

0.4 (0.27%)

LGF.A

Lionsgate

$9.68

-0.315 (-3.15%)

LGF.B

Lionsgate

$9.00

-0.35 (-3.74%)

T

AT&T

$38.24

-0.11 (-0.29%)

CMCSA

Comcast

$43.59

0.57 (1.33%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

DLTR

Dollar Tree

$93.59

1.04 (1.12%)

, DG

Dollar General

$154.75

-0.885 (-0.57%)

14:31
12/15/19
12/15
14:31
12/15/19
14:31
Periodicals
Local governments want dollar stores selling fresh food, WSJ reports »

Local governments across…

DLTR

Dollar Tree

$93.59

1.04 (1.12%)

DG

Dollar General

$154.75

-0.885 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELUXY

Electrolux

$0.00

(0.00%)

14:25
12/15/19
12/15
14:25
12/15/19
14:25
Hot Stocks
Electrolux sees $70M charge in Q4 from North America consolidation »

Electrolux provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCS

Barclays

$9.74

0.655 (7.21%)

, BP

BP

$36.95

-0.005 (-0.01%)

10:39
12/15/19
12/15
10:39
12/15/19
10:39
Recommendations
Barclays, BP, Amadeus IT Group, Anglo American, BT Group, Carlsberg, Demant, E.ON, Intertek, Novartis, Persimmon, Puma, RSA Insurance, Koninklijke Vopak, Hammerson, NMC Health, Reckitt Benckiser, Renault analyst commentary  »

Jefferies gives European…

BCS

Barclays

$9.74

0.655 (7.21%)

BP

BP

$36.95

-0.005 (-0.01%)

AMADY

Amadeus IT Group

$0.00

(0.00%)

NGLOY

Anglo American

$0.00

(0.00%)

BT

BT Group

$0.00

(0.00%)

CABGY

Carlsberg

$0.00

(0.00%)

WILYY

Demant

$0.00

(0.00%)

EONGY

E.ON

$0.00

(0.00%)

IKTSY

Intertek

$0.00

(0.00%)

NVS

Novartis

$93.00

-0.055 (-0.06%)

PSMMY

Persimmon

$0.00

(0.00%)

PUMSY

Puma

$0.00

(0.00%)

RSNAY

RSA Insurance

$0.00

(0.00%)

VOPKY

Koninklijke Vopak

$0.00

(0.00%)

HMSNF

Hammerson

$0.00

(0.00%)

NMHLY

NMC Health

$0.00

(0.00%)

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

RNLSY

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 23

    Mar

SNE

Sony

$67.60

0.285 (0.42%)

, SCOR

comScore

$4.63

-0.41 (-8.13%)

05:55
12/15/19
12/15
05:55
12/15/19
05:55
Hot Stocks
Sony's 'Jumanji' tops weekend box office with $60.1M in sales »

Sony's (SNE)…

SNE

Sony

$67.60

0.285 (0.42%)

SCOR

comScore

$4.63

-0.41 (-8.13%)

DIS

Disney

$146.37

0.4 (0.27%)

LGF.A

Lionsgate

$9.68

-0.315 (-3.15%)

LGF.B

Lionsgate

$9.00

-0.35 (-3.74%)

T

AT&T

$38.24

-0.11 (-0.29%)

CMCSA

Comcast

$43.59

0.57 (1.33%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

, AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

04:55
12/15/19
12/15
04:55
12/15/19
04:55
Conference/Events
Roth Capital to hold a conference »

8th Annual ROTH Deer…

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

BBSI

Barrett Business

$93.18

1.82 (1.99%)

BNGO

Bionano Genomics

$1.02

0.01 (0.99%)

IRMD

iRadimed

$25.25

-0.52 (-2.02%)

FC

Franklin Covey

$35.21

-0.57 (-1.59%)

NBEV

New Age Beverages

$1.91

-0.015 (-0.78%)

WATT

Energous

$1.99

(0.00%)

EAST

Eastside Distilling

$2.79

-0.12 (-4.12%)

DCTH

Delcath Systems

$0.00

(0.00%)

BOOM

DMC Global

$52.89

0.64 (1.22%)

CLAR

Clarus

$13.47

-0.02 (-0.15%)

JRSH

Jerash Holdings

$6.46

(0.00%)

MCHX

Marchex

$3.68

0.03 (0.82%)

JYNT

Joint Corp.

$17.37

0.28 (1.64%)

SOLY

Soliton

$10.35

-0.005 (-0.05%)

SMSI

Smith Micro

$4.66

0.095 (2.08%)

PWFL

PowerFleet

$6.10

0.05 (0.83%)

OSIS

OSI Systems

$100.60

0.63 (0.63%)

LOVE

Lovesac

$10.80

-1.01 (-8.55%)

VERI

Veritone

$2.73

-0.1 (-3.53%)

WTER

Alkaline Water

$1.09

-0.01 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 29

    Jan

PNC

PNC Financial

$158.60

-0.3 (-0.19%)

, PYPL

PayPal

$107.68

2.01 (1.90%)

13:57
12/14/19
12/14
13:57
12/14/19
13:57
Periodicals
PNC clients having trouble connecting to PayPal's Venmo, WSJ reports »

Many of PNC…

PNC

PNC Financial

$158.60

-0.3 (-0.19%)

PYPL

PayPal

$107.68

2.01 (1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 15

    Jan

BRK.A

Berkshire Hathaway

$338,250.51

-992.49 (-0.29%)

, CMCSA

Comcast

$43.59

0.57 (1.33%)

07:44
12/14/19
12/14
07:44
12/14/19
07:44
Periodicals
Berkshire, Anthem among Barron's top 10 stock picks for 2020 »

Barron's has…

BRK.A

Berkshire Hathaway

$338,250.51

-992.49 (-0.29%)

CMCSA

Comcast

$43.59

0.57 (1.33%)

RDS.B

Royal Dutch Shell

$57.41

-0.19 (-0.33%)

RDS.A

Royal Dutch Shell

$57.44

-0.32 (-0.55%)

PFE

Pfizer

$38.31

-0.23 (-0.60%)

VIAC

ViacomCBS

$38.62

0.83 (2.20%)

ANTM

Anthem

$284.14

-0.405 (-0.14%)

DELL

Dell Technologies

$49.39

-0.11 (-0.22%)

GOOG

Alphabet

$1,348.07

-2.09 (-0.15%)

GOOGL

Alphabet Class A

$1,347.11

-1.4 (-0.10%)

UHAL

Amerco

$360.28

7.57 (2.15%)

UTX

United Technologies

$148.99

-0.5 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 27

    Feb

PCG

PG&E

$11.26

-0.49 (-4.17%)

07:38
12/14/19
12/14
07:38
12/14/19
07:38
Hot Stocks
California Governor says PG&E restructuring plan 'falls woefully short' »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.